148 related articles for article (PubMed ID: 18647836)
1. Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249.
Veazey RS; Ketas TA; Klasse PJ; Davison DK; Singletary M; Green LC; Greenberg ML; Moore JP
Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10531-6. PubMed ID: 18647836
[TBL] [Abstract][Full Text] [Related]
2. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
[TBL] [Abstract][Full Text] [Related]
3. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Ketas TJ; Schader SM; Zurita J; Teo E; Polonis V; Lu M; Klasse PJ; Moore JP
Virology; 2007 Aug; 364(2):431-40. PubMed ID: 17428517
[TBL] [Abstract][Full Text] [Related]
4. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
[TBL] [Abstract][Full Text] [Related]
5. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
Veazey RS; Ketas TJ; Dufour J; Moroney-Rasmussen T; Green LC; Klasse PJ; Moore JP
J Infect Dis; 2010 Sep; 202(5):739-44. PubMed ID: 20629537
[TBL] [Abstract][Full Text] [Related]
6. Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.
Barouch DH; Klasse PJ; Dufour J; Veazey RS; Moore JP
Proc Natl Acad Sci U S A; 2012 May; 109(22):8694-8. PubMed ID: 22586094
[TBL] [Abstract][Full Text] [Related]
7. Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.
Veazey RS; Klasse PJ; Ketas TJ; Reeves JD; Piatak M; Kunstman K; Kuhmann SE; Marx PA; Lifson JD; Dufour J; Mefford M; Pandrea I; Wolinsky SM; Doms RW; DeMartino JA; Siciliano SJ; Lyons K; Springer MS; Moore JP
J Exp Med; 2003 Nov; 198(10):1551-62. PubMed ID: 14623909
[TBL] [Abstract][Full Text] [Related]
8. Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.
Boadi T; Schneider E; Chung S; Tsai L; Gettie A; Ratterree M; Blanchard J; Neurath AR; Cheng-Mayer C
AIDS; 2005 Oct; 19(15):1587-94. PubMed ID: 16184027
[TBL] [Abstract][Full Text] [Related]
9. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.
Parren PW; Marx PA; Hessell AJ; Luckay A; Harouse J; Cheng-Mayer C; Moore JP; Burton DR
J Virol; 2001 Sep; 75(17):8340-7. PubMed ID: 11483779
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
11. CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV).
Chen Z; Zhao X; Huang Y; Gettie A; Ba L; Blanchard J; Ho DD
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):133-45. PubMed ID: 12045675
[TBL] [Abstract][Full Text] [Related]
12. Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.
Tsai L; Trunova N; Gettie A; Mohri H; Bohm R; Saifuddin M; Cheng-Mayer C
Virology; 2007 May; 362(1):207-16. PubMed ID: 17258783
[TBL] [Abstract][Full Text] [Related]
13. Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
Wolinsky SM; Veazey RS; Kunstman KJ; Klasse PJ; Dufour J; Marozsan AJ; Springer MS; Moore JP
Virology; 2004 Oct; 328(1):19-29. PubMed ID: 15380354
[TBL] [Abstract][Full Text] [Related]
14. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.
Himathongkham S; Halpin NS; Li J; Stout MW; Miller CJ; Luciw PA
J Virol; 2000 Sep; 74(17):7851-60. PubMed ID: 10933692
[TBL] [Abstract][Full Text] [Related]
15. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
16. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
[TBL] [Abstract][Full Text] [Related]
17. Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.
Emau P; Tian B; O'keefe BR; Mori T; McMahon JB; Palmer KE; Jiang Y; Bekele G; Tsai CC
J Med Primatol; 2007 Aug; 36(4-5):244-53. PubMed ID: 17669213
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
Kish-Catalone T; Pal R; Parrish J; Rose N; Hocker L; Hudacik L; Reitz M; Gallo R; Devico A
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):33-42. PubMed ID: 17263630
[TBL] [Abstract][Full Text] [Related]
19. Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.
Li L; Tan S; Lu H; Lu L; Yang J; Jin H; Liu S; Jiang S
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):384-92. PubMed ID: 21239999
[TBL] [Abstract][Full Text] [Related]
20. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y
J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
